References
- Pirmohamed M . Pharmacogenetics: past, present and future. Drug Discov. Today16(19–20) , 852–861 (2011).
- Zhu H -J, Patrick KS, Yuan H-J et al. Two CES1 gene mutations lead to dysfunctional carbozylesterase 1 activity in man: clinical significance and molecular basis. Am. J. Hum. Genet.82 , 1241–1248 (2008).
- Martini M , VecchioneL, SienaS et al. Targeted therapies: how personal should we go? Nat. Rev. Clin. Oncol. 9 , 87–97 (2012).